Abstract: Disclosed are pharmaceutical compositions comprising tedizolid phosphate, methods of preparing such pharmaceutical compositions, and methods of treating bacterial infections with such pharmaceutical compositions. Specifically, a pharmaceutical composition comprising tedizolid phosphate, an acid; and a suspending agent; and wherein the pH of the composition upon constitution with water is between about pH 2-4.5, is provided, wherein the acid is not citric acid or malic acid.

Abstract: Disclosed are pharmaceutical compositions comprising tedizolid phosphate, methods of preparing such pharmaceutical compositions, and methods of treating bacterial infections with such pharmaceutical compositions. Specifically, a pharmaceutical composition comprising tedizolid phosphate, an acid; and a suspending agent; and wherein the pH of the composition upon constitution with water is between about pH 2-4.5, is provided, wherein the acid is not citric acid or malic acid.

Abstract: The invention is for a method for making a heteropoly acid compound catalyst from compounds containing molybdenum, vanadium, phosphorus, cesium, copper, bismuth, antimony and boron in which molybdenum, vanadium, phosphorus, cesium, copper, bismuth and boron are at their highest oxidation states and antimony has a 3+ oxidation state. The catalyst contains oxides of molybdenum, vanadium, phosphorus, cesium, copper, bismuth, antimony, boron and, optionally, other metals. The catalyst has the formula: Mo12VaPbCscCudBieSbfBgOx where Mo is molybdenum, V is vanadium, P is phosphorus, Cs is cesium, Cu is copper, Bi is bismuth, Sb is antimony, B is boron, O is oxygen, a is 0.01 to 5.0, b is 0.5 to 3.5, c is 0.01 to 2.0, d is 0.0-1.5, e is 0.0-2.0, f is 0.01-3.0, g is 0.0-4.0 and x satisfies the valences. Molybdenum is reduced by antimony and reoxidized during catalyst synthesis.

Abstract: The present disclosure is directed to disintegration systems for solid pharmaceutical dosage forms, which allow rapid disintegration of solid dosage forms that comprise solid dispersion formulations that include pharmaceutically active agents, polymers and optionally surfactants. The present disclosure is also directed to solid pharmaceutical dosage forms, such as tablets, comprising solid dispersion formulations and the disintegration systems, to methods for preparing the disintegration systems, and to methods for preparing the solid pharmaceutical dosage forms.

Abstract: The instant invention relates to pharmaceutical compositions comprising cathespin K inhibitors and Vitamin D.

Abstract: The invention is for a method for making a heteropoly acid compound catalyst from compounds containing molybdenum, vanadium, phosphorus, cesium, copper, bismuth, antimony and boron in which molybdenum, vanadium, phosphorus, cesium, copper, bismuth and boron are at their highest oxidation states and antimony has a 3+ oxidation state. The catalyst contains oxides of molybdenum, vanadium, phosphorus, cesium, copper, bismuth, antimony, boron and, optionally, other metals. The catalyst has the formula: Mo12VaPbCscCudBieSbfBgOx where Mo is molybdenum, V is vanadium, P is phosphorus, Cs is cesium, Cu is copper, Bi is bismuth, Sb is antimony, B is boron, O is oxygen, a is 0.01 to 5.0, b is 0.5 to 3.5, c is 0.01 to 2.0, d is 0.0-1.5, e is 0.0-2.0, f is 0.01-3.0, g is 0.0-4.0 and x satisfies the valences. Molybdenum is reduced by antimony and reoxidized during catalyst synthesis.

Abstract: Methods for making unsaturated acids using catalysts for oxidation of unsaturated and/or saturated aldehyde to unsaturated acids is disclosed where the catalyst including at least molybdenum (Mo) and phosphorus (P), where the catalyst has a pore size distribution including at least 50% medium pores and if bismuth is present, a nitric acid to molybdenum mole ratio of at least 0.5:1 or at least 6.0:1 moles of HNO3 per mole of Mo12.

Abstract: Methods of making catalysts for oxidation of unsaturated and/or saturated aldehyde to unsaturated acids is disclosed where the catalyst including at least molybdenum (Mo) and phosphorus (P), where the catalyst has a pore size distribution including at least 50% medium pores and if bismuth is present, a nitric acid to molybdenum mole ratio of at least 0.5:1 or at least 6.0:1 moles of HNO3 per mole of Mo12.

Abstract: Methods of making catalysts for oxidation of unsaturated and/or saturated aldehyde to unsaturated acids is disclosed where the catalyst including at least molybdenum (Mo) and phosphorus (P), where the catalyst has a pore size distribution including at least 50% medium pores and if bismuth is present, a nitric acid to molybdenum mole ratio of at least 0.5:1 or at least 6.0:1 moles of HNO3 per mole of Mo12.

Abstract: Methods for making unsaturated acids using catalysts for oxidation of unsaturated and/or Saturated aldehyde to unsaturated acids is disclosed where the catalyst including at least molybdenum (Mo) and phosphorus (P), where the catalyst has a pore size distribution including at least 50% medium pores and if bismuth is present, a nitric acid to molybdenum mole ratio of at least 0.5:1 or at least 6.0:1 moles of HNO3 per mole of Mo12.

Abstract: A catalyst for oxidation of unsaturated and/or saturated aldehyde to unsaturated acids is disclosed where the catalyst including at least molybdenum (Mo), phosphorus (P), vanadium (V), bismuth (Bi), and a first component selected from the group consisting of potassium (K), rubidium (Rb), cesium (Cs), thallium (Tl), or mixtures or combinations thereof, where the catalyst has at least 57% medium pores and a nitric acid to molybdenum mole ratio of at least 0.5:1 or at least 6.0:1 moles of HNO3 per mole of Mo12. Methods for making and using such catalysts are also disclosed.

Abstract: The present invention is for a process for making a heteropoly acid compound catalyst for oxidation of unsaturated aldehydes, such as methacrolein, to unsaturated carboxylic acids, such as methacrylic acid, said catalyst containing oxides of molybdenum, phosphorus, and M?, wherein M? is cesium, potassium, rubidium, or sodium, and bismuth. The process is a synthesis of the catalyst with specific process conditions for addition of the bismuth compound as an aqueous slurry without nitric acid. A catalyst precursor is formed by removing the water and drying the solid particles. The heteropoly acid compound catalyst is formed by calcination of the catalyst precursor.

Abstract: The present invention is for a process for making a heteropoly acid compound catalyst for oxidation of unsaturated aldehydes, such as methacrolein, to unsaturated carboxylic acids, such as methacrylic acid, said catalyst containing oxides of molybdenum, phosphorus, and M?, wherein M? is cesium, potassium, rubidium, or sodium, and bismuth. The process is a synthesis of the catalyst with specific process conditions for addition of the bismuth compound as an aqueous slurry without nitric acid. A catalyst precursor is formed by removing the water and drying the solid particles. The heteropoly acid compound catalyst is formed by calcination of the catalyst precursor.

Abstract: A catalyst for oxidation of unsaturated and/or saturated aldehyde to unsaturated acids is disclosed where the catalyst including at least molybdenum (Mo), phosphorus (P), vanadium (V), bismuth (Bi), and a first component selected from the group consisting of potassium (K), rubidium (Rb), cesium (Cs), thallium (Ti), or mixtures or combinations thereof, where the catalyst has at least 57% medium pores and a nitric acid to molybdenum mole ratio of at least 0.5:1 or at least 6.0:1 moles of HNO3 per mole of Mo12. Methods for making and using such catalysts are also disclosed.